ANGIOGUARD RX EMBOLI CAPTURE GUIDEWIRE SYSTEM
Report
- Report Number
- 1016427-2011-00038
- Event Type
- Injury
- Date Received
- May 9, 2011
- Date of Event
- March 23, 2011
- Report Date
- April 12, 2011
- Manufacturer
- CORDIS CORPORATION
- Product Code
- NTE
- PMA / PMN Number
- K062531
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- OTHER
Narratives
COMPLAINT CONCLUSION: THE REPORT RECEIVED FROM THE (B)(4) STUDY INDICATED THAT DURING AN INTERVENTIONAL ENDOVASCULAR PROCEDURE FOR A PRECISE 7 X 30 CAROTID STENT IMPLANTATION THE PATIENT EXPERIENCED HYPOTENSION. THE HYPOTENSION WAS TREATED BY IV INFUSION OF ONE LITER OF CRYSTALLOID AND A PHENYLEPHRINE DRIP TO MAINTAIN A BLOOD PRESSURE ABOVE EIGHTY SYSTOLIC. THE PATIENT HAD NO REPORTED NEUROLOGICAL DEFICIT POST-PROCEDURE. THE PHYSICIAN USED A 5 MM ANGIOGUARD EMBOLIC PROTECTION DEVICE FOR THE PROCEDURE AND THE DEVICE BECAME STRETCHED. THE PATIENT WAS ASYMPTOMATIC FOR THE STUDY INDEX PROCEDURE. THE TARGET LESION WAS THE OSTIUM OF THE RIGHT INTERNAL CAROTID ARTERY (RICA). THE LESION WAS REPORTED TO BE: 15 MM LENGTH, AN 81% STENOSIS, 4.5 MM REFERENCE DIAMETER, AND ABSENT OF THROMBUS. THE LESION WAS PRE-DILATED. THE RESIDUAL STENOSIS WAS 0%. THE PATIENT'S MEDICAL HISTORY INCLUDES: CLINICAL COPD, HISTORY OF SMOKING, DIABETES MELLITUS, CORONARY ARTERY DISEASE AND HYPERTENSION. HIGH RISK CRITERIA: PREVIOUS CEA WITH RECURRENT STENOSIS. (B)(4): THE PRODUCT WAS NOT RETURNED FOR INSPECTION. NOTE: LAKE REGION LOT NUMBER 02427639 WHICH IS CORDIS LOT NUMBER 71010505. PER LAKE REGION REPORT (B)(4): LAKE REGION MEDICAL DID REVIEW THE DEVICE HISTORY RECORDS RELATIVE TO THE MANUFACTURING, INSPECTING AND PACKAGING OF LOT 02427639. THIS PACKAGING LOT CONTAINED 128 UNITS, WHICH WERE SHIPPED FROM LAKE REGION MEDICAL ON (B)(6) 2010. THE HISTORY RECORDS INDICATE THIS PRODUCT WAS FINAL INSPECTION TESTED AT LAKE REGION MEDICAL AND WAS DETERMINED TO BE ACCEPTABLE. HEMODYNAMIC DEPRESSION DURING CAROTID ARTERY STENTING PROCEDURES IS A COMMON EVENT AND IS MOST LIKELY RELATED TO CORONARY SINUS REFLEX OR VAGAL RESPONSE. THE VAGUS NERVE ENTERS THE THORAX BETWEEN COMMON CAROTID ARTERY AND SUBCLAVIAN ARTERY AND DESCENDS DOWNWARD. DURING BALLOON INFLATION OR STENT DEPLOYMENT, PRESSURE CAN BE EXERTED ON THE NERVE STIMULATING A PARASYMPATHETIC RESPONSE, I.E. BRADYCARDIA, HYPOTENSION, HEART BLOCK, ASYSTOLE, ETC. THERE IS NO EVIDENCE TO SUGGEST THAT THIS EVENT IS RELATED TO A MANUFACTURING ISSUE OR DEFECT OF THE DEVICE, BUT IS LIKELY RELATED TO VESSEL CHARACTERISTICS, THE PATIENT'S SIGNIFICANT MEDICAL HISTORY/HIGH RISK CRITERIA AND PROCEDURAL FACTORS. BASED ON THE LACK OF INFORMATION AND THE INABILITY TO ASSIGN OR DETERMINE A ROOT CAUSE NO CORRECTIVE ACTIONS WILL BE TAKEN AT THIS TIME. THIS IS ONE OF TWO PRODUCTS USED DURING THE SAME PROCEDURE. PLEASE REFERENCE MFR. REPORT #1016427-2011-00038 AND # 9616099-2011-00311.
THE PRODUCT IS NOT AVAILABLE FOR EVALUATION AND TESTING. ADDITIONAL INFORMATION WILL BE SUBMITTED WITHIN 30 DAYS UPON RECEIPT. THIS IS ONE OF TWO PRODUCTS USED DURING THE SAME PROCEDURE. PLEASE REFERENCE MFR. REPORT #1016427-2011-00038 AND # 9616099-2011-00311.
THE REPORT RECEIVED FROM THE SAPPHIRE STUDY INDICATED THAT DURING AN INTERVENTIONAL ENDOVASCULAR PROCEDURE FOR A PRECISE 7 X 30 CAROTID STENT IMPLANTATION THE PATIENT EXPERIENCED HYPOTENSION. THE HYPOTENSION WAS TREATED BY IV INFUSION OF ONE LITER OF CRYSTALOID AND A PHENYLEPHRINE DRIP TO MAINTAIN A BLOOD PRESSURE ABOVE EIGHTY SYSTOLIC. THE PATIENT HAD NO REPORTED NEUROLOGICAL DEFICIT POST-PROCEDURE. THE PHYSICIAN USED A 5 MM ANGIOGUARD EMBOLIC PROTECTION DEVICE FOR THE PROCEDURE AND THE DEVICE BECAME STRETCHED. ANOTHER ANGIOGUARD WAS USED TO COMPLETE THE PROCEDURE SUCCESSFULLY. THE PATIENT WAS ASYMPTOMATIC FOR THE STUDY INDEX PROCEDURE. THE TARGET LESION WAS THE OSTIUM OF THE RIGHT INTERNAL CAROTID ARTERY (RICA). THE LESION WAS REPORTED TO BE: 15 MM LENGTH, AN 81% STENOSIS, 4.5 MM REFERENCE DIAMETER, AND ABSENT OF THROMBUS. THE LESION WAS PRE-DILATED. THE RESIDUAL STENOSIS WAS 0%.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ANGIOGUARD RX EMBOLI CAPTURE GUIDEWIRE SYSTEM | EMBOLIC PROTECTION DEVICE (NTE) | NTE | CORDIS CORPORATION | NA | 71010505 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | Hospitalization| L| R | PRECISE 7 X 30 STENT |